首页> 美国政府科技报告 >Targeting Quiescent Cancer Cells to Eliminate Tumor Recurrence After Therapy.

【24h】

Targeting Quiescent Cancer Cells to Eliminate Tumor Recurrence After Therapy.

机译：靶向静止癌细胞以消除治疗后的肿瘤复发。

获取原文

页面导航

著录项
相似文献
相关主题

著录项

作者
Nie, D.;
展开▼
作者单位

展开▼
年度 2016
页码 1-16
总页数 16
原文格式 PDF
正文语种 eng
中图分类
关键词
Lung cancer; Therapeutics; Chemotherapy; Chemoresistance; Quiescent tumor cells; Proliferating tumor cells;

机译：肺癌;治疗学;化学疗法;化学抗性;静止肿瘤细胞;增殖性肿瘤细胞;

相似文献

外文文献
中文文献
专利

1. Knockdown of oncogenic KRAS in non-small cell lung cancers suppresses tumor growth and sensitizes tumor cells to targeted therapy. [J] . Sunaga N, Shames DS, Girard L, Molecular cancer therapeutics . 2011,第2期

机译：降低非小细胞肺癌中的致癌性KRAS抑制肿瘤生长并使肿瘤细胞对靶向治疗敏感。
2. Tumor-targeting Salmonella typhimurium A1-R decoys quiescent cancer cells to cycle as visualized by FUCCI imaging and become sensitive to chemotherapy [J] . Yano Shuya, Zhang Yong, Zhao Ming, Cell cycle . 2014,第24期

机译：靶向肿瘤的鼠伤寒沙门氏菌A1-R诱饵使静止的癌细胞循环（如FUCCI成像所示）并对化学疗法敏感
3. New Response Evaluation Criteria in Solid Tumors (RECIST) guidelines for advanced non-small cell lung cancer: comparison with original RECIST and impact on assessment of tumor response to targeted therapy. [J] . Nishino M, Jackman DM, Hatabu H, AJR: American Journal of Roentgenology : Including Diagnostic Radiology, Radiation Oncology, Nuclear Medicine, Ultrasonography and Related Basic Sciences . 2010,第3期

机译：晚期非小细胞肺癌新的实体瘤反应评估标准（RECIST）指南：与原始RECIST的比较及其对靶向治疗肿瘤反应评估的影响。
4. Gene Expression and Pathway Analysis of Quiescent CD8+ T Cells from Liver Cancer, Liver Sinusoid and Peripheral Blood - Study on Toxicogenomics and Prevention Targeting [C] . Wang Zhaohui, Hu Hongliang, Zheng Jie, 11th IEEE International Conference on BioInformatics and BioEngineering . 2011

机译：肝癌，肝窦和外周血中静止的CD8 + T细胞的基因表达和途径分析-毒物基因组学和预防靶标研究
5. Abrogating the Protumorigenic Impact of Tumor-Infiltrating Myeloid Cells During Prostate Cancer Therapy. [D] . Escamilla, Jemima. 2013

机译：在前列腺癌治疗过程中减低肿瘤浸润性髓样细胞的致瘤作用。
6. Targeting the Roots of Recurrence: New Strategies for Eliminating Therapy-Resistant Breast Cancer Stem Cells [O] . Margaret L. Dahn, Paola Marcato 2021

机译：针对复发的根源：消除抗治疗乳腺癌干细胞的新策略
7. ErbB receptorok szerepe epitél eredetű tumorokban: receptor tirozinkinázok, mint a tumor ellenes terápiák lehetséges target molekulái. = Role of ErbB receptors in epithelial tumors: receptor tyrosine kinases as targets for anticancer therapy. [O] . Szöllősi János, Barok Márk, Fazekas Zsolt, 2007

机译：ErbB受体在上皮肿瘤中的作用：受体酪氨酸激酶是抗肿瘤治疗的潜在靶分子。 = ErbB受体在上皮肿瘤中的作用：受体酪氨酸激酶作为抗癌治疗的靶标。

Targeting Quiescent Cancer Cells to Eliminate Tumor Recurrence After Therapy.

著录项

相似文献

相关主题

期刊订阅